PPARGC1A and Alzheimer disease: Comparison between control and CIH+AD groups showed that a) no significant difference in Cycs levels; b) a statistically higher PGC1-α level in CIH+AD group; c) a significantly lower Esrrα and Nrf1 levels in CIH+AD group.